and we expect utilization to continue to expand significantly in 2021 with really a goal of having more than 50 % of our shoulder procedures using pre-surgical planning .
net sales in the fourth quarter were $ 2.085 billion , a reported decrease of 1.9 % and a constant currency decrease of 3.7 % versus 2019 .
the q4 adjusted tax rate of 15 % was better than the previous year due to geographic mix of income and certain discrete benefits in the quarter , related to recent audit settlements .
we did realize our 2020 expectations of $ 100 million in gross revenue and almost $ 40 million in net of cannibalization revenue during the year .
adjusted gross margin was 71.3 % , sequentially better than q3 , but lower than q4 2019 .
and then finally for signature one planner , we demonstrated this again , strong sequential growth with registrations up nearly 25 % in q4 over q3 .
and if i just look at q4 specifically , we grew about 30 % over q3 , again , even with the increased pressures of the pandemic in q4 , so very excited with what we 're able to do with avenir complete .
our global hip business decreased 3.4 % , again driven by declines in emea .
in fact , the spin - off transaction that we 're going to do over the next year serves to de-risk if not accelerate our path to that 4 % to 5 % growth rate that we have talked about and our 30 % operating margin profile by the end of 2023 .
however , the u.s. knee business continued to grow , increasing 1.8 % , and asia - pacific knee business returned to growth , increasing 2.9 % .
sports , extremity , and trauma sales declined 3.3 % .
moving to the p&l , we reported gaap diluted earnings per share of $ 1.59 and adjusted diluted earnings per share of $ 2.11 .
both u.s. hips and apac hips continued their growth trends , increasing 1.4 % and 1.3 % respectively .
lastly , the americas region was about flat , decreasing 0.3 % compared to 2019 , driven by continued covid headwinds in latin america , in tandem with a softening u.s. market .
and in terms of capital allocation , we remain committed to maintaining our investment - grade rating and are planning to pay down an additional $ 500 million of debt in 2021 .
beginning with asia -pacific , the region grew 2 % versus q4 2019 with growth across all three of our largest markets of japan , china and australia / new zealand .
